Catalyst signs agreement with NIDA for phase IIb vigabatrin trial for cocaine addiction April 15, 2010
Interim clinical data on varenicline for smoking cessation in bipolar depression disclosed March 19, 2010
Protalix initiates phase I trial of PRX-105 acetylcholinesterase for biodefense indications March 18, 2010
RSS